BSE filing, NSE: INDRANIB. Summary written from the filing by ALFA Finder's alert engine.
Indrayani Biotech Ltd: key numbers
- Share price
- ₹7.66
- Market cap
- ₹41.11 Cr
- Revenue (annual)
- ₹137.8 Cr
- Net profit (annual)
- ₹2.16 Cr
- P/E (TTM)
- 19.6×Sector 27.9×
- Promoter holding
- 32.92%-0.34% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indrayani Biotech Ltd
All →Indrayani Biotech Capital Structure Change
Indrayani Biotech allotted 83,64,036 rights equity shares at Rs 15 (75,03,333 fully paid) and Rs 3.75 (8,60,703 partly paid). Issue receipts total about Rs 11.58 Crore.
- Value
- ₹11.58 Cr
Indrayani Biotech Capital Structure Change
Indrayani Biotech's committee allotted 83,64,036 partly paid rights shares at Rs.15 each, worth about Rs.12.55 crore. Application money of Rs.3.75 per share has been received.
- Value
- ₹12.55 Cr
Indrayani Biotech Board Meeting Date
Indrayani Biotech Ltd has scheduled a Board meeting for November 06, 2026. The meeting will primarily consider the notice for the company's 34th Annual General Meeting.
Indrayani Biotech Board Meeting Outcome
Indrayani Biotech appointed Ms. N. S. Poornima as Secretarial Auditor for FY 2025-26 to fill a casual vacancy. Company Secretary C.S. Shanmuga Sundar's resignation took effect on 2 November 2026.
Indrayani Biotech Legal & Regulatory
Indrayani Biotech received a tax recovery notice for outstanding demands totaling ₹1.17 Crore for various assessment years, for which the company has filed responses.
- Value
- ₹1.17 Cr
Indrayani Biotech Management Change
Independent Director Mr. K.S. Vaidyanathan has resigned from the Board of Indrayani Biotech Limited, effective October 13, 2026, due to personal reasons.
Other management change announcements
All →Shipwaves Online Management Change
Shipwaves Online appointee Head of Sales Sheel Ruparelia resigned effective 4 Nov 2026 to pursue new opportunities. No other material reasons for departure were disclosed.
Trans India House Impex Management Change
Trans India House Impex appointed three Independent Directors effective November 4, 2026. Board committees including Audit and Nomination were reconstituted accordingly.
Cera Sanitaryware Management Change
Cera Sanitaryware's board approved re-appointment of Vikram Somany as CMD and Anandh Sundar as Independent Director for 5-year terms starting 2027. Both remain subject to shareholder approval.
Amit Securities Management Change
Amit Securities Ltd disclosed that Independent Director Pradeep Kumar Sharma's tenure has completed. No new appointment was announced in this filing.
Harrisons Malayalam Management Change
Harrisons Malayalam disclosed the resignation of Non-Executive Non-Independent Director Mr. Kaushik Roy, effective 3 November 2026, citing personal reasons. No other material reasons were stated.
Chembond Chemicals Management Change
Chembond Chemicals appointed Mr. Ravi Kumar Mutaka as Chief Operating Officer effective 4 November 2026. He brings over 30 years of chemical industry and FMCG operational experience.